MarketInOut Stock Screener Log In | Sign Up
 

Intercure Ltd

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 05/14/2026 09:31
Intercure Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization44.86 mln
Float35.19 mln
Earnings Date05/01/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-1.54
Likely manipulated

Relative Strength

32 / 100
Underperforming

Debt / Equity

0.42
Low leverage

ROE

-16.51
Negative

Dividend Yield

0.00%
No dividend

Business Description

InterCure Ltd. is an Israeli company that grows, produces, and sells medical-grade cannabis and cannabis-based products to patients in Israel and abroad, offering both dried cannabis flower and oil-based extracts. The company also holds investments in the biomedical sector and works closely with Cannasoul R&D Ltd. to develop and bring to market cannabis treatments backed by clinical research. Founded in 1994 and based in Herzliya, Israel, InterCure operates across the full supply chain from cultivation to distribution.

Key Fundamentals

EPS-0.23
ROE-16.51
RPS1.63
ROIC-5.99
ROA-9.44
EBITDA, mln-23.39
EV / EBITDA-3.87
EV / EBIT-3.87
Revenue, mln81.06
EV / Revenue1.12

Financial Strength

Altman Z-Score0.01
Piotroski F-Score 2 / 9
Beneish M-Score-1.54
Short Ratio0.34
Short % of Float0.02

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.91% 33 / 100   
1 Month 10.18% 78 / 100   
2 Months -4.08% 31 / 100   
6 Months -41.5% 15 / 100   
1 Year -46.08% 14 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us